Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articlesA major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
A major federal loan initiative aims to revitalize nuclear power by backing five new projects with $17.5 billion. Thi...
As the fed's preferred inflation metric climbs above 4%, investors face questions about rate paths and portfolio reso...
Regulators have signaled close scrutiny of a possible Paramount-Warner Bros. merger, threatening delays and potential...
Investors eye the long end of the curve as Kevin Warsh's QT stance shifts income dynamics. Forget utility dividends. ...
A surprising rally in small-cap value equities challenges the usual price-pressures from inflation and higher rates. ...
SpaceX's leadership reshapes the space economy. This article highlights three powerful space stocks that could benefi...
When big builders cut prices to move inventory, investors win—if they know how to structure deals. This guide breaks ...
The idea of lifelong renters isn’t just a buzzword—it's reshaping how landlords approach financing, property manageme...
What would a new Fed chair do if inflation stayed stubborn while growth slowed? This article imagines Chair Kevin War...
Dreaming of a destination wedding? This budget-focused guide draws on the Venice-inspired celebrations around Giannin...
A fresh email alleging a secret phone may hold evidence in a missing-person case has sparked online chatter. This gui...